FIGNL1: Fidgetin-Like 1 – A Microtubule-Severing ATPase in Cell Division and DNA Repair

Comprehensive genomic and functional overview of FIGNL1, a key regulator of spindle dynamics and homologous recombination.

Gene Information Card

Symbol FIGNL1
Full Name Fidgetin-like 1
Gene Type Protein-coding
Chromosomal Location 7p12.2
NCBI Gene ID 63979 ncbi.nlm.nih.gov/gene/63979
Ensembl ID ENSG00000105835
UniProt ID Q6PIJ6
OMIM ID 614846
HGNC ID 25914
Aliases FLJ10597, MGC131831, dJ1181N3.1

Description

FIGNL1 (fidgetin-like 1) encodes a member of the AAA ATPase family that severs microtubules and regulates spindle dynamics during mitosis. The protein also participates in homologous recombination-mediated DNA repair by promoting RAD51 filament disassembly. FIGNL1 is essential for proper cell division and genome stability, and its dysregulation is implicated in cancer and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Overexpression may promote genomic instability by altering RAD51 dynamics; associated with poor prognosis. ClinVar, COSMIC
Ovarian cancer Amplification and overexpression observed; potential role in chemoresistance via homologous recombination. COSMIC, literature
Primary microcephaly Loss-of-function mutations impair spindle assembly, leading to reduced brain size. OMIM #614846
Lung adenocarcinoma Somatic mutations and copy number gains linked to tumor progression. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Bone marrow 8.3 Low
Lymph node 7.1 Low
Brain 4.2 Not detected
Heart 3.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical cancer cell line; high expression
MCF7 11.8 Breast cancer cell line; moderate expression
A549 9.5 Lung cancer cell line; moderate expression
K562 6.3 Leukemia cell line; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.01% Loss of ATPase activity; associated with microcephaly
c.1420G>A (p.Glu474Lys) Missense 0.02% Impaired RAD51 interaction; potential gain-of-function in cancer
c.1789_1790insA (p.Thr597Asnfs*2) Frameshift <0.01% Loss-of-function; truncation
c.2044C>T (p.Arg682*) Nonsense <0.01% Premature stop; loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg682*, p.Thr597Asnfs*2) that truncate the protein or disrupt the AAA ATPase domain, leading to impaired microtubule severing and RAD51 filament disassembly.

Gain of Function (GOF)

Missense mutations (e.g., p.Glu474Lys) that enhance RAD51 binding or ATPase activity, potentially driving genomic instability in cancer.

Dominant Negative (DN)

Missense mutations (e.g., p.Arg339Trp) that produce a defective protein capable of interfering with wild-type FIGNL1 function in spindle assembly.

Pathways

Homologous recombination (Reactome: R-HSA-5693568)
Cell cycle
mitotic (Reactome: R-HSA-69278)
Resolution of D-loop structures (Reactome: R-HSA-5693571)

Protein Summary

FIGNL1 is a 789-amino acid AAA ATPase that localizes to the mitotic spindle and centrosomes. It severs microtubules to regulate spindle length and chromosome segregation. In DNA repair, FIGNL1 removes RAD51 from single-stranded DNA after homologous recombination, preventing aberrant recombination. The protein contains an N-terminal AAA domain and a C-terminal RAD51-binding region. Structural studies show that ATP hydrolysis drives conformational changes required for microtubule severing and RAD51 filament disassembly.

Related Products

Product name Cat.No. Species Gene ID
FIGNL1 Knockout HEK293 Cell Line EDJ-KQ13487 Human 63979 Details Get a Quote
FIGNL1 Knockout A-549 Cell Line EDJ-KQ43086 Human 63979 Details Get a Quote
FIGNL1 Knockout HCT 116 Cell Line EDJ-KQ43087 Human 63979 Details Get a Quote
FIGNL1 Knockout HeLa Cell Line EDJ-KQ43088 Human 63979 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: